Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank18
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-28.42%
↓ 48% vs avg
Percentile
P18
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-19.23%
Historical baseline
PeriodValue
Q4 2025-28.42%
Q3 2025-1.66%
Q2 2025-8.81%
Q1 2025-15.25%
Q4 2024-8.69%
Q3 2024-4.04%
Q2 2024-21.68%
Q1 2024-15.55%
Q4 2023-54.68%
Q3 2023-44.25%
Q2 2023-27.72%
Q1 20230.00%